Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems

Yosuke K. Kurokawa, Rose T. Yin, Michael R. Shang, Venktesh S. Shirure, Monica L. Moya, Steven George

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Microphysiological systems (MPS), or "organ-on-a-chip" platforms, aim to recapitulate in vivo physiology using small-scale in vitro tissue models of human physiology. While significant efforts have been made to create vascularized tissues, most reports utilize primary endothelial cells that hinder reproducibility. In this study, we report the use of human induced pluripotent stem cell-derived endothelial cells (iPS-ECs) in developing three-dimensional (3D) microvascular networks. We established a CDH5-mCherry reporter iPS cell line, which expresses the vascular endothelial (VE)-cadherin fused to mCherry. The iPS-ECs demonstrate physiological functions characteristic of primary endothelial cells in a series of in vitro assays, including permeability, response to shear stress, and the expression of endothelial markers (CD31, von Willibrand factor, and endothelial nitric oxide synthase). The iPS-ECs form stable, perfusable microvessels over the course of 14 days when cultured within 3D microfluidic devices. We also demonstrate that inhibition of TGF-β signaling improves vascular network formation by the iPS-ECs. We conclude that iPS-ECs can be a source of endothelial cells in MPS providing opportunities for human disease modeling and improving the reproducibility of 3D vascular networks.

Original languageEnglish (US)
Pages (from-to)474-484
Number of pages11
JournalTissue Engineering - Part C: Methods
Volume23
Issue number8
DOIs
StatePublished - Aug 1 2017
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Endothelial cells
Stem cells
Endothelial Cells
Physiology
Lab-On-A-Chip Devices
Microvessels
Blood Vessels
Tissue
Nitric Oxide Synthase Type III
Nitric oxide
Microfluidics
Shear stress
Permeability
Assays
Cells
Cell Line

Keywords

  • endothelial cells
  • induced pluripotent stem cells
  • microfluidics
  • vascularization

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems. / Kurokawa, Yosuke K.; Yin, Rose T.; Shang, Michael R.; Shirure, Venktesh S.; Moya, Monica L.; George, Steven.

In: Tissue Engineering - Part C: Methods, Vol. 23, No. 8, 01.08.2017, p. 474-484.

Research output: Contribution to journalArticle

Kurokawa, Yosuke K. ; Yin, Rose T. ; Shang, Michael R. ; Shirure, Venktesh S. ; Moya, Monica L. ; George, Steven. / Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems. In: Tissue Engineering - Part C: Methods. 2017 ; Vol. 23, No. 8. pp. 474-484.
@article{058f257c5ea84c08b408aa806438db47,
title = "Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems",
abstract = "Microphysiological systems (MPS), or {"}organ-on-a-chip{"} platforms, aim to recapitulate in vivo physiology using small-scale in vitro tissue models of human physiology. While significant efforts have been made to create vascularized tissues, most reports utilize primary endothelial cells that hinder reproducibility. In this study, we report the use of human induced pluripotent stem cell-derived endothelial cells (iPS-ECs) in developing three-dimensional (3D) microvascular networks. We established a CDH5-mCherry reporter iPS cell line, which expresses the vascular endothelial (VE)-cadherin fused to mCherry. The iPS-ECs demonstrate physiological functions characteristic of primary endothelial cells in a series of in vitro assays, including permeability, response to shear stress, and the expression of endothelial markers (CD31, von Willibrand factor, and endothelial nitric oxide synthase). The iPS-ECs form stable, perfusable microvessels over the course of 14 days when cultured within 3D microfluidic devices. We also demonstrate that inhibition of TGF-β signaling improves vascular network formation by the iPS-ECs. We conclude that iPS-ECs can be a source of endothelial cells in MPS providing opportunities for human disease modeling and improving the reproducibility of 3D vascular networks.",
keywords = "endothelial cells, induced pluripotent stem cells, microfluidics, vascularization",
author = "Kurokawa, {Yosuke K.} and Yin, {Rose T.} and Shang, {Michael R.} and Shirure, {Venktesh S.} and Moya, {Monica L.} and Steven George",
year = "2017",
month = "8",
day = "1",
doi = "10.1089/ten.tec.2017.0133",
language = "English (US)",
volume = "23",
pages = "474--484",
journal = "Tissue Engineering - Part C: Methods",
issn = "1937-3384",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems

AU - Kurokawa, Yosuke K.

AU - Yin, Rose T.

AU - Shang, Michael R.

AU - Shirure, Venktesh S.

AU - Moya, Monica L.

AU - George, Steven

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Microphysiological systems (MPS), or "organ-on-a-chip" platforms, aim to recapitulate in vivo physiology using small-scale in vitro tissue models of human physiology. While significant efforts have been made to create vascularized tissues, most reports utilize primary endothelial cells that hinder reproducibility. In this study, we report the use of human induced pluripotent stem cell-derived endothelial cells (iPS-ECs) in developing three-dimensional (3D) microvascular networks. We established a CDH5-mCherry reporter iPS cell line, which expresses the vascular endothelial (VE)-cadherin fused to mCherry. The iPS-ECs demonstrate physiological functions characteristic of primary endothelial cells in a series of in vitro assays, including permeability, response to shear stress, and the expression of endothelial markers (CD31, von Willibrand factor, and endothelial nitric oxide synthase). The iPS-ECs form stable, perfusable microvessels over the course of 14 days when cultured within 3D microfluidic devices. We also demonstrate that inhibition of TGF-β signaling improves vascular network formation by the iPS-ECs. We conclude that iPS-ECs can be a source of endothelial cells in MPS providing opportunities for human disease modeling and improving the reproducibility of 3D vascular networks.

AB - Microphysiological systems (MPS), or "organ-on-a-chip" platforms, aim to recapitulate in vivo physiology using small-scale in vitro tissue models of human physiology. While significant efforts have been made to create vascularized tissues, most reports utilize primary endothelial cells that hinder reproducibility. In this study, we report the use of human induced pluripotent stem cell-derived endothelial cells (iPS-ECs) in developing three-dimensional (3D) microvascular networks. We established a CDH5-mCherry reporter iPS cell line, which expresses the vascular endothelial (VE)-cadherin fused to mCherry. The iPS-ECs demonstrate physiological functions characteristic of primary endothelial cells in a series of in vitro assays, including permeability, response to shear stress, and the expression of endothelial markers (CD31, von Willibrand factor, and endothelial nitric oxide synthase). The iPS-ECs form stable, perfusable microvessels over the course of 14 days when cultured within 3D microfluidic devices. We also demonstrate that inhibition of TGF-β signaling improves vascular network formation by the iPS-ECs. We conclude that iPS-ECs can be a source of endothelial cells in MPS providing opportunities for human disease modeling and improving the reproducibility of 3D vascular networks.

KW - endothelial cells

KW - induced pluripotent stem cells

KW - microfluidics

KW - vascularization

UR - http://www.scopus.com/inward/record.url?scp=85027454424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027454424&partnerID=8YFLogxK

U2 - 10.1089/ten.tec.2017.0133

DO - 10.1089/ten.tec.2017.0133

M3 - Article

C2 - 28622076

AN - SCOPUS:85027454424

VL - 23

SP - 474

EP - 484

JO - Tissue Engineering - Part C: Methods

JF - Tissue Engineering - Part C: Methods

SN - 1937-3384

IS - 8

ER -